^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Lyophilized formulation tested.

^e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^f Test performed using the formulation WITHOUT edetate disodium.

^g Tested in sodium chloride 0.45%.

^h Injected via Y-site into an administration set running azithromycin.

ⁱ Final concentration after mixing.

^j Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^k Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^l Quinupristin and dalfopristin components combined.

^m Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

ⁿ Not specified whether concentration refers to single component or combined components.

^o Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^p Test performed using the Cubicin formulation.

^q Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^r Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^s Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^t Test performed using the formulation WITH edetate disodium.

^u Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^v Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.